MedTrace Logo

Allogeneic Cord Blood for Neurological Diseases in Adults

NCT05515419 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2025-09-10

No results posted yet for this study

Summary

This open label trial is conducted to investigate the efficacy and safety of allogeneic umbilical cord blood therapy for adult patients with neurological diseases.

Conditions

Interventions

BIOLOGICAL

Allogeneic cord blood treatment

Allogeneic cord blood treatment

Sponsors & Collaborators

  • The Medical Pavilion Bahamas

    lead OTHER

Principal Investigators

  • Conville S Brown, MD · The Medical Pavilion Bahamas

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2026-09-30
Completion
2026-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05515419 on ClinicalTrials.gov